D-Cycloserine Augmentation of Exposure and Response Prevention Treatment for Obsessive-Compulsive Disorder
Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
We propose to undertake an initial study of DCS to determine whether it has any short-term
clinical benefits when added to standard ERP therapy in adults with OCD.